-
公开(公告)号:US20100034887A1
公开(公告)日:2010-02-11
申请号:US12086657
申请日:2006-12-21
申请人: Polonca Kuhar , Peter Svete , Judita Sirca
发明人: Polonca Kuhar , Peter Svete , Judita Sirca
IPC分类号: A61K9/14 , A61K31/415 , A61P19/02
CPC分类号: A61K9/1652 , A61K9/1617 , A61K9/1623 , A61K31/415
摘要: In the present invention, a new pharmaceutical formulation of bursting pellets comprising in the core a high dose of a low potency active substance which is poorly soluble in water is described. Release of the active substance from the core takes place within minutes.
摘要翻译: 在本发明中,描述了一种爆炸性丸剂的新药物制剂,其在核心中含有高剂量的低溶性活性物质,其水溶性差。 活性物质从核心的释放发生在几分钟之内。
-
公开(公告)号:US20070141149A1
公开(公告)日:2007-06-21
申请号:US10583440
申请日:2004-12-22
申请人: Polonca Kuhar , Judita Sirca
发明人: Polonca Kuhar , Judita Sirca
CPC分类号: A61K31/18 , A61K9/1635 , A61K9/5026
摘要: In the present invention, a new pharmaceutical formulation with controlled release of the freely water soluble low-dose active substance used for at the most once daily administration is disclosed. The active substance is maintained at a suitable therapeutic concentration in the blood throughout at least a 24 hour period independent of the physiological pH value to which the pharmaceutical formulation is exposed.
摘要翻译: 在本发明中,公开了一种每日一次给药最多一次使用的自由水溶性低剂量活性物质的控制释放的新型药物制剂。 活性物质在药物制剂暴露的生理pH值独立的至少24小时内保持在血液中合适的治疗浓度。
-
公开(公告)号:US08642078B2
公开(公告)日:2014-02-04
申请号:US12294571
申请日:2007-03-29
申请人: Igor Legen , Polonca Kuhar
发明人: Igor Legen , Polonca Kuhar
IPC分类号: A61K9/54 , A61K9/62 , A61K9/20 , A61K31/205
CPC分类号: A61K9/5047 , A61K31/137
摘要: A sustained release pharmaceutical composition comprising coating comprising at least one water-insoluble permeable polymer and at least one water soluble polymer and homogenous cores containing only tolterodine or a salt thereof and microcrystalline cellulose is described.
摘要翻译: 描述了包含至少一种水不溶性可渗透聚合物和至少一种水溶性聚合物的涂层的缓释药物组合物和仅含有托特罗定或其盐的微粒纤维素和微晶纤维素。
-
公开(公告)号:US20090214642A1
公开(公告)日:2009-08-27
申请号:US12294571
申请日:2007-03-29
申请人: Igor Legen , Polonca Kuhar
发明人: Igor Legen , Polonca Kuhar
CPC分类号: A61K9/5047 , A61K31/137
摘要: A sustained release pharmaceutical composition comprising coating comprising at least one water-insoluble permeable polymer and at least one water soluble polymer and homogenous cores containing only tolterodine or a salt thereof and microcrystalline cellulose is described.
摘要翻译: 描述了包含至少一种水不溶性可渗透聚合物和至少一种水溶性聚合物的涂层的缓释药物组合物和仅含有托特罗定或其盐和微晶纤维素的均质芯。
-
-
-